发明名称 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TYPE 2 DIABETES IN MAMMALS INCLUDING HUMAN BEINGS |
摘要 |
The present invention provides a pharmaceutical composition for the treatment of type 2 diabetes in mammals including human beings, wherein the pharmaceutical composition contains (3aS, 5s, 6aR)-5-(2-((2S, 4S)-2-cyano-4-fluoropyrrolidin-1-yl)-2-oxo-ethylamino)-N, N, 5-trimethyl-hexahydro-cyclopenta[C]pyrrole-2(1H)-carboxamide or its pharmaceutically acceptable salts and rosiglitazone or pioglitazone or their pharmaceutically acceptable salts, preparation method thereof and the use of the pharmaceutical composition in manufacture of medicaments for treating type 2 diabetes in mammals including human beings. |
申请公布号 |
WO2010142182(A1) |
申请公布日期 |
2010.12.16 |
申请号 |
WO2010CN72709 |
申请日期 |
2010.05.13 |
申请人 |
JIANGSU HENGRUI MEDICINE CO., LTD.;MA, SHUQIN;YUAN, KAIHONG;LIU, HUAWEN;ZHU, YAFEI |
发明人 |
MA, SHUQIN;YUAN, KAIHONG;LIU, HUAWEN;ZHU, YAFEI |
分类号 |
A61K31/403;A61K9/08;A61K9/14;A61K9/16;A61K9/20;A61K9/22;A61K9/48;A61K9/52;A61K31/4436;A61K31/4439;A61P3/10;C07D209/52;C07D403/12 |
主分类号 |
A61K31/403 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|